CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The I-MOVE+ project aims to evaluate the effectiveness of influenza and pneumococcal vaccines in the elderly across Europe. It seeks to establish a collaborative platform for sharing validated methods to assess vaccine performance and guide vaccination strategies.
The I-MOVE+ Consortium includes European Union (EU) Public Health Institutes, SME and Universities.
It aims at measuring and comparing the effectiveness (VE) and impact (VI) of influenza and Pneumococcal vaccines and vaccination strategies a in the elderly population in Europe.
The goal is to develop a sustainable platform of primary care practices, hospitals and laboratory networks that share validated methods to evaluate post marketing vaccine performances.
The objectives are to identify, pilo…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Sutton Surrey
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
ASOCIACION INSTITUTO BIOGIPUZKOA
Spain, DONOSTIA-SAN SEBASTIAN
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
